AAREY DRUGS & PHARMACEUTICALS
|
AAREY DRUGS & PHARMACEUTICALS Last 5 Year Balance Sheet History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹28 Cr | ₹25 Cr | ₹25 Cr | ₹23 Cr | ₹23 Cr |
Equity - Authorised | ₹36 Cr | ₹26 Cr | ₹26 Cr | ₹25 Cr | ₹25 Cr |
Equity - Issued | ₹28 Cr | ₹25 Cr | ₹25 Cr | ₹23 Cr | ₹23 Cr |
Equity Paid Up | ₹28 Cr | ₹25 Cr | ₹25 Cr | ₹23 Cr | ₹23 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | ₹2.47 Cr | ₹2.32 Cr | ₹2.32 Cr | ₹2.32 Cr | ₹2.32 Cr |
Total Reserves | ₹102 Cr | ₹90 Cr | ₹86 Cr | ₹73 Cr | ₹67 Cr |
Securities Premium | ₹49 Cr | ₹41 Cr | ₹41 Cr | ₹35 Cr | ₹35 Cr |
Capital Reserves | ₹0.20 Cr | ₹0.20 Cr | ₹0.20 Cr | ₹0.20 Cr | ₹0.20 Cr |
Profit & Loss Account Balance | ₹53 Cr | ₹48 Cr | ₹45 Cr | ₹38 Cr | ₹32 Cr |
General Reserves | - | - | - | - | - |
Other Reserves | ₹0.02 Cr | - | - | - | - |
Reserve excluding Revaluation Reserve | ₹102 Cr | ₹90 Cr | ₹86 Cr | ₹73 Cr | ₹67 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹133 Cr | ₹117 Cr | ₹114 Cr | ₹99 Cr | ₹92 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹3.22 Cr | ₹4.36 Cr | ₹3.34 Cr | - | ₹0.02 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | - | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹3.22 Cr | ₹4.36 Cr | ₹3.34 Cr | - | ₹0.02 Cr |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹0.75 Cr | ₹1.42 Cr | ₹1.46 Cr | ₹1.56 Cr | ₹1.44 Cr |
Deferred Tax Assets | - | - | - | - | - |
Deferred Tax Liability | ₹0.75 Cr | ₹1.42 Cr | ₹1.46 Cr | ₹1.56 Cr | ₹1.44 Cr |
Other Long Term Liabilities | - | - | - | - | - |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | - | - | - | ₹1.81 Cr | - |
Total Non-Current Liabilities | ₹3.97 Cr | ₹5.78 Cr | ₹4.80 Cr | ₹3.37 Cr | ₹1.46 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹129 Cr | ₹127 Cr | ₹110 Cr | ₹110 Cr | ₹78 Cr |
Sundry Creditors | ₹129 Cr | ₹127 Cr | ₹110 Cr | ₹110 Cr | ₹78 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹5.41 Cr | ₹2.18 Cr | ₹1.03 Cr | ₹0.78 Cr | ₹2.00 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹5.07 Cr | ₹3.38 Cr | ₹0.89 Cr | - | - |
Interest Accrued But Not Due | - | - | - | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹0.35 Cr | ₹-1.20 Cr | ₹0.14 Cr | ₹0.78 Cr | ₹2.00 Cr |
Short Term Borrowings | ₹28 Cr | ₹33 Cr | ₹11 Cr | ₹18 Cr | ₹18 Cr |
Secured ST Loans repayable on Demands | ₹28 Cr | ₹33 Cr | ₹11 Cr | ₹17 Cr | ₹17 Cr |
Working Capital Loans- Sec | ₹28 Cr | ₹33 Cr | ₹11 Cr | ₹17 Cr | ₹17 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-28 Cr | ₹-33 Cr | ₹-11 Cr | ₹-17 Cr | ₹-17 Cr |
Short Term Provisions | ₹4.07 Cr | ₹5.28 Cr | ₹5.23 Cr | ₹1.66 Cr | ₹2.66 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹3.85 Cr | ₹5.06 Cr | ₹4.83 Cr | ₹1.66 Cr | ₹2.66 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹0.22 Cr | ₹0.22 Cr | ₹0.40 Cr | - | - |
Total Current Liabilities | ₹167 Cr | ₹168 Cr | ₹127 Cr | ₹131 Cr | ₹100 Cr |
Total Liabilities | ₹303 Cr | ₹291 Cr | ₹245 Cr | ₹233 Cr | ₹194 Cr |
ASSETS | |||||
Gross Block | ₹34 Cr | ₹33 Cr | ₹32 Cr | ₹30 Cr | ₹27 Cr |
Less: Accumulated Depreciation | ₹21 Cr | ₹19 Cr | ₹18 Cr | ₹16 Cr | ₹15 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹13 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹12 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | - | - | - | - | - |
Non Current Investments | ₹1.38 Cr | ₹0.40 Cr | ₹0.40 Cr | ₹0.40 Cr | ₹0.44 Cr |
Long Term Investment | ₹1.38 Cr | ₹0.40 Cr | ₹0.40 Cr | ₹0.40 Cr | ₹0.44 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹1.38 Cr | ₹0.40 Cr | ₹0.40 Cr | ₹0.40 Cr | ₹0.44 Cr |
Long Term Loans & Advances | ₹6.36 Cr | ₹6.37 Cr | ₹9.09 Cr | - | - |
Other Non Current Assets | ₹0.01 Cr | ₹0.01 Cr | ₹2.40 Cr | - | - |
Total Non-Current Assets | ₹21 Cr | ₹21 Cr | ₹26 Cr | ₹15 Cr | ₹13 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹35 Cr | ₹29 Cr | ₹14 Cr | ₹18 Cr | ₹17 Cr |
Raw Materials | ₹11 Cr | ₹7.10 Cr | ₹4.92 Cr | ₹4.02 Cr | - |
Work-in Progress | ₹0.81 Cr | ₹1.75 Cr | ₹0.26 Cr | ₹0.53 Cr | - |
Finished Goods | ₹5.22 Cr | ₹11 Cr | ₹3.57 Cr | ₹2.68 Cr | - |
Packing Materials | - | - | - | - | - |
Stores  and Spare | - | - | - | - | - |
Other Inventory | ₹18 Cr | ₹9.27 Cr | ₹4.93 Cr | ₹11 Cr | ₹17 Cr |
Sundry Debtors | ₹184 Cr | ₹190 Cr | ₹136 Cr | ₹162 Cr | ₹96 Cr |
Debtors more than Six months | ₹20 Cr | ₹19 Cr | ₹21 Cr | ₹17 Cr | - |
Debtors Others | ₹165 Cr | ₹170 Cr | ₹115 Cr | ₹145 Cr | ₹96 Cr |
Cash and Bank | ₹1.59 Cr | ₹0.71 Cr | ₹0.19 Cr | ₹0.65 Cr | ₹0.50 Cr |
Cash in hand | ₹1.49 Cr | ₹0.70 Cr | ₹0.16 Cr | ₹0.01 Cr | ₹0.49 Cr |
Balances at Bank | ₹0.10 Cr | ₹0.01 Cr | ₹0.03 Cr | ₹0.64 Cr | ₹0.02 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹2.72 Cr | ₹0.75 Cr | ₹0.53 Cr | ₹2.81 Cr | ₹0.05 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | ₹2.69 Cr | ₹0.71 Cr | ₹0.47 Cr | ₹2.77 Cr | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | - | - | - | - | - |
Other current_assets | ₹0.04 Cr | ₹0.04 Cr | ₹0.06 Cr | ₹0.04 Cr | ₹0.05 Cr |
Short Term Loans and Advances | ₹59 Cr | ₹51 Cr | ₹68 Cr | ₹34 Cr | ₹68 Cr |
Advances recoverable in cash or in kind | ₹40 Cr | ₹39 Cr | ₹66 Cr | ₹31 Cr | ₹61 Cr |
Advance income tax and TDS | ₹0.79 Cr | ₹0.84 Cr | ₹0.48 Cr | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹18 Cr | ₹11 Cr | ₹1.55 Cr | ₹3.73 Cr | ₹6.44 Cr |
Total Current Assets | ₹283 Cr | ₹271 Cr | ₹219 Cr | ₹218 Cr | ₹181 Cr |
Net Current Assets (Including Current Investments) | ₹116 Cr | ₹102 Cr | ₹92 Cr | ₹88 Cr | ₹81 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹303 Cr | ₹291 Cr | ₹245 Cr | ₹233 Cr | ₹194 Cr |
Contingent Liabilities | - | - | - | - | - |
Total Debt | ₹31 Cr | ₹38 Cr | ₹14 Cr | ₹18 Cr | ₹18 Cr |
Book Value | - | 45.34 | 43.85 | 41.29 | 38.50 |
Adjusted Book Value | 46.45 | 45.34 | 43.85 | 41.29 | 38.50 |
Compare Balance Sheet of peers of AAREY DRUGS & PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AAREY DRUGS & PHARMACEUTICALS | ₹180.1 Cr | 10.9% | 2.6% | 31.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,544.0 Cr | 2.8% | -2.7% | 50.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,865.0 Cr | 3.5% | 5.4% | 67.6% | Stock Analytics | |
CIPLA | ₹123,920.0 Cr | 2.9% | -1.2% | 25.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,224.0 Cr | 2.1% | -3.9% | 6.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,832.3 Cr | 3.3% | -2% | 53.5% | Stock Analytics |
AAREY DRUGS & PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AAREY DRUGS & PHARMACEUTICALS | 10.9% |
2.6% |
31.4% |
SENSEX | 1.1% |
1.1% |
22.2% |
You may also like the below Video Courses